Postoperative Level of C-Reactive Protein Is a Prognosticator After Esophageal Cancer Surgery With Perioperative Steroid Therapy and Enhanced Recovery After Surgery Care

Abstract

Background: This study investigated the impact of postoperative C-reactive protein (CRP) level on survival in patients with esophageal cancer who received perioperative steroid therapy and enhanced recovery after surgery (ERAS) care. Patients and Methods: Overall, 115 patients were retrospectively reviewed. The patients were classified into those with a high CRP level (≥4.0 mg/dl) on postoperative day 4 and those with low CRP level (<4.0 mg/dl). The risk factors for overall survival (OS) and recurrence-free survival (RFS) were identified. Results: The OS and RFS rates at 5 years after surgery were significantly low in patients with high CRP level on postoperative day 4. The multivariate analysis demonstrated that high CRP level on postoperative day 4 was a significant independent risk factor for OS and RFS. Conclusion: The present results suggest that the postoperative CRP level can be a prognosticator in patients with esophageal cancer who have received perioperative steroid therapy and ERAS care. Esophageal cancer is the world's eighth most-common cancer and the sixth leading cause of cancer-related death among those with cancer (1). Multimodal therapy, including curative resection and perioperative adjuvant treatment, is 587 This article is freely accessible online.

The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

“…34) The proper blood glucose control has been reported to decrease the inflammation after surgery, thus leading to better long-term outcomes of cancer patients receiving surgery. 35,36) And this effect is more remarkable among diabetic patients since they have a poor glucose tolerance. Therefore, a precise and accurate management while during later stage IGF-1R signaling was not required for further progression.…”

Effect of Enhanced Recovery after Surgery with Integrated Traditional Chinese and Western Medicine on Postoperative Stress Response of Patients with Gastrointestinal Tumors

“…ERAS has been widely applied in the postoperative recovery of tumor surgery, such as liver resection for hepatocellular carcinoma [24], esophagectomy [25], pulmonary lobectomy for lung cancer [26], gastrectomy for gastric cancer [27], and colorectal cancer surgery [28]. Besides, a study on Japanese patients indicated that ERAS can help colorectal cancer patients rapidly recover, and the postoperative hospitalization time of patients who applied ERAS was evidently shorter than that of patients in the control group [29].…”

The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric Cancer

“…Recent studies have also reported the preoperative inflammatory response to be related to tumor metastasis, tumor invasion, and chemotherapy resistance via damage to DNA, the promotion of angiogenesis, and the inhibition of apoptosis (5)(6)(7)(8). In addition, some studies have shown that both short-and longterm oncological outcomes are affected by the inflammatory response during the perioperative period in gastrointestinal cancer (9,10).…”